Primary Record
Torasemide
- In stock
- 3,775 g
- Purity
- 99.3 %
- CAS
- 56211-40-6
Compound Identifiers & Properties
- CAS
- 56211-40-6
- PubChem CID
- 41781
- SMILES
- CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
- Canonical SMILES
- Cc1cccc(Nc2ccncc2S(=O)(=O)NC(=O)NC(C)C)c1
Names & Synonyms
- Torasemide
- TORSEMIDE
- Demadex
- Luprac
- 56211-40-6
- Torasemida
- Torasemidum
- Toradiur
- Soaanz
- Upcard
- Torem
- Unat
- Presoril
- Torocard
- Dilutol
- Sutril
- Torrem
- Torasemide anhydrous
- Torsemide [USAN]
- Torasemide N
- Torsemid
- Torsemide-d7
- Torasemidum [INN-Latin]
- Torasemida [INN-Spanish]
- Torsemide (USP)
- Torasemide [INN]
- Demadex (TN)
- Luprac (TN)
- Torsemide (Demadex)
- Demadex, Torsemide
- Torasemide, Anhydrous
- Torem 5
- Torsemide/Torasemide
- UpCArd-CA1
- Torsemide (Standard)
- Torasemide (JAN/INN)
- Torem 10
- JDL 464
- Torsemide [USAN:USP]
- Spectrum_001776
- Torem 2.5
- AC-4464
- BM-02015
- A1ATU
- RefChem:57833
- DTXSID2023690
- TORSEMIDE [MI]
- AC4464
- C16H20N4O3S
- Torasemide anhydrous CRS
- AC1Q6UVM
- TORASEMIDE [JAN]
- Prestwick0_001030
- Prestwick1_001030
- Prestwick2_001030
- Prestwick3_001030
- Spectrum2_001142
- Spectrum3_001832
- Spectrum4_000290
- Spectrum5_001699
- CCRIS 6736
- TORSEMIDE [VANDF]
- UNII-W31X2H97FB
- W31X2H97FB
- AC 4464
- UpCArd-CA1 TORSEMIDE
- D0J9XZ
- JDL-464
- MLS001165687
- TORASEMIDE [MART.]
- TORSEMIDE [USP-RS]
- BM 02015
- CHEBI:9637
- DTXCID203690
- CHEMBL1148
- TORASEMIDE [WHO-DD]
- SCHEMBL41184
- BSPBio_001219
- BSPBio_003503
- KBioGR_000820
- KBioSS_002257
- cid_41781
- MLS000759418
- MLS001195611
- MLS001424121
- MLS006010744
- BIDD:GT0623
- BM02.015
- SPECTRUM1505211
- GJ-1090
- SPBio_001063
- SPBio_003080
- MFCD00866166
- NGBFQHCMQULJNZ-UHFFFAOYSA-N
- AC1L26H7
- BPBio1_001341
- GTPL7312
- orb1308696
- orb3025016
- ZINC5823
- TORSEMIDE [ORANGE BOOK]
- SCHEMBL29369134
- SCHEMBL29395363
- TORSEMIDE [USP IMPURITY]
- BDBM64107
- CTK8B3035
- HY-B0247R
- KBio2_002256
- KBio2_004824
- KBio2_007392
- KBio3_003008
- Torasemide for system suitability
- BM-02.015
- BRN 0498515
- C03CA04
- N-(Isopropylcarbamoyl)-4-(m-tolylamino)pyridine-3-sulfonamide
- TORASEMIDE [EP MONOGRAPH]
- TORSEMIDE [USP MONOGRAPH]
- 1-Isopropyl-3-((4-m-toluidino-3-pyridyl)sulfonyl)urea
- GLXC-23564
- HMS1571M21
- HMS1922N05
- HMS2051L21
- HMS2098M21
- HMS2234N14
- HMS3373G20
- HMS3393L21
- HMS3715M21
- HMS3744G19
- HMS5087M17
- ACN-S001245
- ALBB-027267
- BCP07286
- CID41781
- HY-B0247
- KS-1123
- MSK10502
- PW-2132
- Tox21_110662
- AN-919
- ANW-41652
- C16-H20-N4-O3-S
- CCG-40257
- CID:41781
- CT0260
- EBC-06044
- NCGC00016879-01
- s1698
- STL388026
- SMR000466313
- Torasemide for system suitability CRS
- Torsemide, >=98% (HPLC), solid
- AKOS015894937
- Tox21_110662_1
- 1-[4-(3-methylanilino)pyridin-3-yl]sulfonyl-3-propan-2-ylurea
- BM02015
- CS-2227
- DB00214
- FT28331
- NC00238
- VA11897
- CAS-56211-40-6
- NCGC00016879-02
- NCGC00016879-03
- NCGC00016879-04
- NCGC00016879-06
- NCGC00016879-07
- NCGC00095141-01
- NCGC00095141-02
- NCGC00095141-03
- AC-18762
- AK163579
- CPD000466313
- J11.135J
- SAM001246567
- SC-13773
- SID:376229628
- AB0006854
- AB2000227
- LS-131973
- N-(((1-Methylethyl)amino)carbonyl)-4-((3-methylphenyl)amino)-3-pyridinesulfonamide
- TL8003646
- TR-019752
- AB00514011
- B2055
- FT-0630689
- FT-0675300
- NS00000548
- R3923
- T2538
- D00382
- EN300-118719
- T72621
- 1-isopropyl-3-((4-(3-methylphenylamino)pyridine)-3-sulfonyl)urea
- AB00514011-09
- AB00514011_10
- AB00514011_11
- 1-{4-[(3-methylphenyl)amino]pyridine-3-sulfonyl}-3-(propan-2-yl)urea
- 211T406
- 3-Pyridinesulfonamide, N-(((1-methylethyl)amino)carbonyl)-4-((3-methylphenyl)amino)-
- A830961
- C026116
- Q419948
- SR-01000759362
- TORASEMIDE ANHYDROUS [EMA EPAR VETERINARY]
- I06-0056
- SR-01000759362-5
- 1-isopropyl-3-[[4-(3-methylanilino)-3-pyridyl]sulfonyl]urea
- 2-METHOXY-5-METHYL-4-PHENYLCARBAMOYLIMIDAZOLE
- 3-Pyridinesulfonamide, N-[[(1-methylethyl)amino]carbonyl]-4-[(3-methylphenyl)amino]-
- BRD-K30480208-001-05-2
- BRD-K30480208-001-17-7
- BRD-K30480208-001-18-5
- 1-isopropyl-3-[(4-m-toluidino-3-pyridyl) sulfonyl]urea
- 1-isopropyl-3-[(4-m-toluidino-3-pyridyl)sulfonyl]urea
- D000077786
- N-[(isopropylamino)carbonyl]-4-[(3-methylphenyl)amino]pyridine-3-sulfonamide
- Z1515385087
- 1-(4-(3-Methylanilino)-3-pyridylsulfonyl)-3-isopropylurea
- 1-isopropyl-3-[(4- m -toluidino-3-pyridyl) sulfonyl]urea
- 1-({4-[(3-methylphenyl)amino]pyridin-3-yl}sulfonyl)-3-(propan-2-yl)urea
- 4-[(3-methylphenyl)amino]-N-(propan-2-ylcarbamoyl)pyridine-3-sulfonamide
- Torsemide, United States Pharmacopeia (USP) Reference Standard
- 1-ISOPROPYL-3-((4-M-TOLUIDINO-3-PYRIDYL)SULPHONYL)UREA
- 4-(3-methylanilino)-N-(propan-2-ylcarbamoyl)pyridine-3-sulfonamide
- n-[[(1-methylethyl)amino]carbonyl]-4-[(3-methylphenyl)amino]-3-pyridinesulfonamide
- N-{[(1-methylethyl)amino]carbonyl}-4-[(3-methylphenyl)amino]pyridine-3-sulfonamide
- Torasemide anhydrous, European Pharmacopoeia (EP) Reference Standard
- 1-(4-((3-methylphenyl)amino)pyridine-3-sulfonyl)-3-(propan-2-yl)urea
- 1189375-06-1
- 4-(3-Methylanilino)-N-[(propan-2-yl)carbamoyl]pyridine-3-sulfonamide
- N-(Isopropylaminocarbonyl)-4-(3-methylphenylamino)pyridin-3-ylsulfonamide
- N-(Isopropylaminocarbonyl)-4-(3-methylphenylamino)pyridine-3-sulfonamide
- N-(Isopropylaminocarbonyl)-4-[(3-methylphenyl)amino]-3-pyridinesulfonamide
- N-(isopropylcarbamoyl)-4-[(3-methylphenyl)amino]pyridine-3-sulfonamide
- N-[(propan-2-yl)carbamoyl]-4-[(3-methylphenyl)amino]pyridine-3-sulfonamide
- 3-pyridinesulfonamide,N-(((1-methylethyl)amino)carbonyl)-4-((3-methylphenyl)amino)-
- N-((4-((3-methylphenyl)imino)-1,4-dihydropyridin-3-yl)sulfonyl)propane-2-carbamimidic acid
- N-({4-[(3-methylphenyl)imino]-1,4-dihydropyridin-3-yl}sulfonyl)propane-2-carbamimidic acid
- Torasemide for system suitability, European Pharmacopoeia (EP) Reference Standard
- Torasemide anhydrous; 1-(1-Methylethyl)-3-[[4-[(3-methylphenyl)amino]pyridin-3-yl]sulfonyl]urea; N-[[(1-Methylethyl)amino]carbonyl]-4-[(3-methylphenyl)amino]-3-pyridinesulfonamide